Email RIS file
Bookmark
Report an Issue

The Canadian research and development pharmaceutical sector, 2021 / by Christopher Collins, Karine Garneau, Nicole Minnema, and Thomas Wood

Author
Collins, Christopher
Published
[Ottawa] : Statistics Canada = Statistique Canada, 2024.
Copyright Date
©2024
Edition
[Cat. No.: CS11-621/164E-PDF].
Physical Description
1 online resource (31 pages) : maps, graphs
Additional Creators
Statistics Canada
Access Online

Availability

I Want It
I Want It

Finding items...

Series
Restrictions on Access
Free-to-read Unrestricted online access
Summary
"This report updates the economic footprint study last conducted on the research and development (R&D) pharmaceutical sector in 2020 with new content for 2021. Innovative Medicines Canada (IMC) paid for the report, and it was produced by the Centre for Innovation, Technology and Enterprise Statistics at Statistics Canada. The pharmaceutical sector's economic contribution can be seen through various measures, such as the government tax revenue generated by the sector, its employment and job creation, R&D investment, and international trade"--Introduction, page 5.
Report Numbers
CS11-621/164E-PDF
Subject(s)
Genre(s)
ISBN
9780660718644
0660718642
Note
Distributed by the Government of Canada Publishing and Depository Services Program (Weekly acquisitions list 2024-24).
Issued also in French under title: Le secteur pharmaceutique canadien de la recherche et développement, 2021.
"Release date: June 10, 2024."
"Catalogue no. 11-621-M."
Cover title.
Other Edition
Collins, Christopher. [Cat. No.: CS11-621/164F-PDF]. [Ottawa] : Statistique Canada = Statistics Canada, 2024
Bibliography Note
Includes bibliographical references.
View MARC record | catkey: 46453666